According to latest analysis by Gen Consulting Company, the global osteoarthritis treatment market is poised to grow by USD 2.3 billion during 2022-2028, progressing at a CAGR of 5.3% during the forecast period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global osteoarthritis treatment market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the osteoarthritis treatment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug, anatomy, and region. The global market for osteoarthritis treatment can be segmented by drug: non-steroidal anti-inflammatory drug (NSAID), corticosteroid, hyaluronic acid injection, others. According to the research, the non-steroidal anti-inflammatory drug (NSAID) segment had the largest share in the global osteoarthritis treatment market. Osteoarthritis treatment market is further segmented by anatomy: ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, others. In 2021, the knee osteoarthritis segment made up the largest share of revenue generated by the osteoarthritis treatment market. Based on region, the osteoarthritis treatment market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2021.

Market Segmentation
By drug: non-steroidal anti-inflammatory drug (NSAID), corticosteroid, hyaluronic acid injection, others
By anatomy: ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Osteoarthritis Treatment Market, including Abbott Laboratories, Anika Therapeutics Inc., Assertio Holdings Inc., Bayer AG, Glaxosmithkline plc, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi SA, Zimmer Biomet Holdings, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global osteoarthritis treatment market.
– To classify and forecast the global osteoarthritis treatment market based on drug, anatomy, region.
– To identify drivers and challenges for the global osteoarthritis treatment market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global osteoarthritis treatment market.
– To identify and analyze the profile of leading players operating in the global osteoarthritis treatment market.

Why Choose This Report
– Gain a reliable outlook of the global osteoarthritis treatment market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.